chunk.id	cdr3.alpha	v.alpha	j.alpha	cdr3.beta	v.beta	d.beta	j.beta	species	mhc.a	mhc.b	mhc.class	antigen.epitope	antigen.gene	antigen.species	reference.id	method.identification	method.frequency	method.singlecell	method.sequencing	method.verification	meta.study.id	meta.cell.subset	meta.subset.frequency	meta.subject.cohort	meta.subject.id	meta.replica.id	meta.clone.id	meta.epitope.id	meta.tissue	meta.donor.MHC	meta.donor.MHC.method	meta.structure.id
1				CSQGRGSGFEQF	TRBV1-1		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	3%		sanger			CD8+			I	post-challenge		33510	TCL			
2				CSPNSYEQF	TRBV1-6		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	4%		sanger			CD8+			I	post-immunization		33510	TCL			
3				CSYNSYEQF	TRBV1-6		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			I	post-immunization		33510	TCL			
4				CSRKDFGGDYGELF	TRBV1-7		TRBJ3-1	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	4%		sanger			CD8+			I	post-immunization		33510	TCL			
5				CSQGSGGAYEQF	TRBV1-7		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	4%		sanger			CD8+			I	post-immunization		33510	TCL			
6				CSEDRTARERF	TRBV1-13		TRBJ2-5	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			I	post-immunization		33510	TCL			
7				CQWGGSNEEQF	TRBV2-3		TRBJ2-1	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			I	post-immunization		33510	TCL			
8				CQWGGSYEEQF	TRBV2-4		TRBJ2-1	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	14%		sanger			CD8+			I	post-immunization		33510	TCL			
9				CSRKGGGLQSTQF	TRBV3-1		TRBJ2-3	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			I	post-immunization		33510	TCL			
10				CSPILAWETLF	TRBV6-2		TRBJ2-4	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	3%		sanger			CD8+			I	post-challenge		33510	TCL			
11				CSKSLFEIQF	TRBV8-2		TRBJ3-5	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			I	post-immunization		33510	TCL			
12				CSYETSGYGELF	TRBV8-2		TRBJ3-1	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	1.5%		sanger			CD8+			I	post-challenge		33510	TCL			
13				CSQADSGAYEQF	TRBV10-2		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			I	post-immunization		33510	TCL			
14				CHIRGGLDTQPLF	TRBV12-1		TRBJ3-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	4%		sanger			CD8+			I	post-immunization		33510	TCL			
15				CGEQF	TRBV12-1		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	6%		sanger			CD8+			I	post-immunization		33510	TCL			
16				CSHAGYEQF	TRBV13-2		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	8%		sanger			CD8+			I	post-immunization		33510	TCL			
17				CSSSLLDTQF	TRBV13-4		TRBJ3-4	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	3%		sanger			CD8+			I	post-challenge		33510	TCL			
18				CSYSGSITLQDYF	TRBV13-5		TRBJ1-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			I	post-immunization		33510	TCL			
19				CGHLVGGTRELF	TRBV13-7		TRBJ3-1	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			I	post-immunization		33510	TCL			
20				CSQGQQGYVNNPLF	TRBV13-8		TRBJ3-3	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	1.5%		sanger			CD8+			I	post-challenge		33510	TCL			
21				CSYARDIGAEVF	TRBV13-8		TRBJ1-1	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	4%		sanger			CD8+			I	post-immunization		33510	TCL			
22				CGSPDYF	TRBV13-9		TRBJ1-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			I	post-immunization		33510	TCL			
23				CSYGGNEQF	TRBV13-9		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			I	post-immunization		33510	TCL			
24				CSESQGANYDYF	TRBV14-1		TRBJ1-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	6%		sanger			CD8+			I	post-immunization		33510	TCL			
25				CATGPLQIQF	TRBV14-1		TRBJ3-5	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			I	post-immunization		33510	TCL			
26				CSSVFGGDLKSYEQF	TRBV17-1		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			I	post-immunization		33510	TCL			
27				CWDSGSDYF	TRBV17-3		TRBJ1-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			I	post-immunization		33510	TCL			
28				CAEYGGENTQPLF	TRBV28-1		TRBJ3-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	4%		sanger			CD8+			I	post-immunization		33510	TCL			
29				CAEYGGENTQPLF	TRBV28-1		TRBJ3-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	6%		sanger			CD8+			I	post-immunization		33510	TCL			
30				CAEYGGENTQPLF	TRBV28-1		TRBJ3-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	4%		sanger			CD8+			I	post-immunization		33510	TCL			
31				CGGRDSIYDYF	TRBV28-1		TRBJ1-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	4%		sanger			CD8+			I	post-immunization		33510	TCL			
32				CADTSDTQF	TRBV28-1		TRBJ3-4	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			I	post-immunization		33510	TCL			
33				CSPNSYEQF	TRBV1-6		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	3%		sanger			CD8+			I	post-challenge		33510	TCL			
34				CQWGGSYEEQF	TRBV2-4		TRBJ2-1	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	10%		sanger			CD8+			I	post-challenge		33510	TCL			
35				CSKSLFEIQF	TRBV8-2		TRBJ3-5	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	3%		sanger			CD8+			I	post-challenge		33510	TCL			
36				CHIRGGLDTQPLF	TRBV12-1		TRBJ3-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	6%		sanger			CD8+			I	post-challenge		33510	TCL			
37				CGEQF	TRBV12-1		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	3%		sanger			CD8+			I	post-challenge		33510	TCL			
38				CSHAGYEQF	TRBV13-2		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	1.5%		sanger			CD8+			I	post-challenge		33510	TCL			
39				CSYSGSITLQDYF	TRBV13-5		TRBJ1-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	1.5%		sanger			CD8+			I	post-challenge		33510	TCL			
40				CGHLVGGTRELF	TRBV13-7		TRBJ3-1	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	7%		sanger			CD8+			I	post-challenge		33510	TCL			
41				CSESQGANYDYF	TRBV14-1		TRBJ1-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	7%		sanger			CD8+			I	post-challenge		33510	TCL			
42				CSSVFGGDLKSYEQF	TRBV17-1		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	9%		sanger			CD8+			I	post-challenge		33510	TCL			
43				CWDSGSDYF	TRBV17-3		TRBJ1-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	1.5%		sanger			CD8+			I	post-challenge		33510	TCL			
44				CAEYGGENTQPLF	TRBV28-1		TRBJ3-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	3%		sanger			CD8+			I	post-challenge		33510	TCL			
45				CAEYGGENTQPLF	TRBV28-1		TRBJ3-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	22%		sanger			CD8+			I	post-challenge		33510	TCL			
46				CGGRDSIYDYF	TRBV28-1		TRBJ1-2	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	10%		sanger			CD8+			I	post-challenge		33510	TCL			
47				CSPNSYEQF	TRBV1-6		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			II	post-challenge		33510	TCL			
48				CSQVGGIYGELF	TRBV1-7		TRBJ3-1	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	5%		sanger			CD8+			II	post-immunization		33510	TCL			
49				CRFGPGGLSYEQF	TRBV2-4		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	1.5%		sanger			CD8+			II	post-immunization		33510	TCL			
50				CGVGTRLSYEQF	TRBV4-6		TRBJ3-7	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	8%		sanger			CD8+			II	post-immunization		33510	TCL			
51				CRRAVMNDPLF	TRBV10-4		TRBJ3-3	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	2%		sanger			CD8+			II	post-challenge		33510	TCL			
52				CSLVGRETLF	TRBV12-1		TRBJ2-4	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	1.5%		sanger			CD8+			II	post-immunization		33510	TCL			
53				CSYSPGGGSPLF	TRBV12-2		TRBJ3-3	BosTaurus	MHC-A*10	B2M	MHCI	KSSHGMGKVGK	Tp2	TheileriaParva	PMID:22058411	antigen-expressing-targets,limiting-dilution-cloning	3%		sanger			CD8+			II	post-immunization		33510	TCL			
